120 related articles for article (PubMed ID: 37718120)
1. Improvement of hedonic perception of odors as a marker of treatment response to escitalopram: olfactory changes through an open-label antidepressant trial.
Kazour F; Atanasova B; Desmidt T; Gissot V; Lefevre A; Camus V; Belzung C; El-Hage W
Braz J Psychiatry; 2023; 45(5):414-422. PubMed ID: 37718120
[TBL] [Abstract][Full Text] [Related]
2. Olfactory markers for depression: Differences between bipolar and unipolar patients.
Kazour F; Richa S; Abi Char C; Surget A; Elhage W; Atanasova B
PLoS One; 2020; 15(8):e0237565. PubMed ID: 32791517
[TBL] [Abstract][Full Text] [Related]
3. Assessment of odor hedonic perception: the Sniffin' sticks parosmia test (SSParoT).
Liu DT; Welge-Lüssen A; Besser G; Mueller CA; Renner B
Sci Rep; 2020 Oct; 10(1):18019. PubMed ID: 33093474
[TBL] [Abstract][Full Text] [Related]
4. State and trait olfactory markers of major depression.
Naudin M; El-Hage W; Gomes M; Gaillard P; Belzung C; Atanasova B
PLoS One; 2012; 7(10):e46938. PubMed ID: 23056535
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report.
Kennedy SH; Lam RW; Rotzinger S; Milev RV; Blier P; Downar J; Evans KR; Farzan F; Foster JA; Frey BN; Giacobbe P; Hall GB; Harkness KL; Hassel S; Ismail Z; Leri F; McInerney S; MacQueen GM; Minuzzi L; Müller DJ; Parikh SV; Placenza FM; Quilty LC; Ravindran AV; Sassi RB; Soares CN; Strother SC; Turecki G; Vaccarino AL; Vila-Rodriguez F; Yu J; Uher R;
J Clin Psychiatry; 2019 Feb; 80(2):. PubMed ID: 30840787
[TBL] [Abstract][Full Text] [Related]
6. Mania associated olfactory dysfunction: A comparison between bipolar subjects in mania and remission.
Kazour F; Atanasova B; Mourad M; El Hachem C; Desmidt T; Richa S; El-Hage W
J Psychiatr Res; 2022 Dec; 156():330-338. PubMed ID: 36323136
[TBL] [Abstract][Full Text] [Related]
7. Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.
Soares CN; Thase ME; Clayton A; Guico-Pabia CJ; Focht K; Jiang Q; Kornstein SG; Ninan PT; Kane CP
CNS Drugs; 2011 Mar; 25(3):227-38. PubMed ID: 21323394
[TBL] [Abstract][Full Text] [Related]
8. Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study report.
Espinola CW; Khoo Y; Parmar R; Demchenko I; Frey BN; Milev RV; Ravindran AV; Parikh SV; Ho K; Rotzinger S; Lou W; Lam RW; Kennedy SH; Bhat V
J Psychopharmacol; 2022 May; 36(5):604-613. PubMed ID: 35546043
[TBL] [Abstract][Full Text] [Related]
9. Perceptive biases in major depressive episode.
Naudin M; Carl T; Surguladze S; Guillen C; Gaillard P; Belzung C; El-Hage W; Atanasova B
PLoS One; 2014; 9(2):e86832. PubMed ID: 24558363
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
11. Impact of Hedonics and Magnitude Upon Validated Psychophysical Olfactory Tests and Olfactory-Specific Quality of Life.
Shih MC; Soler ZM; Germroth M; Snyder J; Nguyen SA; Schlosser RJ
Am J Rhinol Allergy; 2023 May; 37(3):253-263. PubMed ID: 36341557
[TBL] [Abstract][Full Text] [Related]
12. The psychophysical assessment of odor valence: does an anchor stimulus influence the hedonic evaluation of odors?
Clepce M; Neumann K; Martus P; Nitsch M; Wielopolski J; Koch A; Kornhuber J; Reich K; Thuerauf N
Chem Senses; 2014 Jan; 39(1):17-25. PubMed ID: 24214346
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of efficacy and tolerability of vilazodone, escitalopram, and amitriptyline in patients of major depressive disorder: A randomized, parallel, open-label clinical study.
Kadam RL; Sontakke SD; Tiple P; Motghare VM; Bajait CS; Kalikar MV
Indian J Pharmacol; 2020; 52(2):79-85. PubMed ID: 32565594
[TBL] [Abstract][Full Text] [Related]
14. Olfactory identification in patients with schizophrenia - the influence of β-endorphin and calcitonin gene-related peptide concentrations.
Urban-Kowalczyk M; Śmigielski J; Strzelecki D
Eur Psychiatry; 2017 Mar; 41():16-20. PubMed ID: 28049076
[TBL] [Abstract][Full Text] [Related]
15. The applicability of the "Sniffin' Sticks" olfactory test in a Turkish population.
Tekeli H; Altundağ A; Salihoğlu M; Cayönü M; Kendirli MT
Med Sci Monit; 2013 Dec; 19():1221-6. PubMed ID: 24382345
[TBL] [Abstract][Full Text] [Related]
16. Patient Response Trajectories in Major Depressive Disorder.
Larsen KG; Kennedy SH; Reines EH; Thase ME
Psychopharmacol Bull; 2020 Sep; 50(4):8-28. PubMed ID: 33012870
[TBL] [Abstract][Full Text] [Related]
17. Olfactory anhedonia and negative olfactory alliesthesia in depressed patients.
Atanasova B; El-Hage W; Chabanet C; Gaillard P; Belzung C; Camus V
Psychiatry Res; 2010 Apr; 176(2-3):190-6. PubMed ID: 20207422
[TBL] [Abstract][Full Text] [Related]
18. Cross-cultural application of the "Sniffin' Sticks" odor identification test.
Shu CH; Yuan BC; Lin SH; Lin CZ
Am J Rhinol; 2007; 21(5):570-3. PubMed ID: 17999792
[TBL] [Abstract][Full Text] [Related]
19. [Clinical application of Sniffin' Sticks olfactory psychophysical measurements].
Yang L; Wei YX; Ren YY; Yu D; Sun YX; Yang BB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Sep; 48(9):741-5. PubMed ID: 24330876
[TBL] [Abstract][Full Text] [Related]
20. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial.
Ventura D; Armstrong EP; Skrepnek GH; Haim Erder M
Curr Med Res Opin; 2007 Feb; 23(2):245-50. PubMed ID: 17288677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
